Tuberculosis Research Challenges - TB Drug Accelerator Webinar

13 December: Collaborative Drug Discovery (CDD) will host a webinar discussing an innovative collaboration in the discovery and development of drugs to treat Tuberculosis

Image of tuberculosis bacterial cells and a macrophage

Hear Dr. Ben Gold and Dr. Dale Kempf, members of the TB Drug Accelerator Program (TBDA), discuss the challenges of Tuberculosis (TB) research and how TBDA is tackling this terrible disease. The webinar will be moderated by Dr. Peter Warner from Bill and Melinda Gates Foundation. 

The TBDA brings together seven major biopharmaceutical companies with leading academic, non-profit and government researchers to “identify new ways to target bacteria that are resistant to current drug regimens, develop new tools for drug discovery, and discover new drugs that can lead to accelerated treatments.”

Date & Time: Wednesday, 13 December 2017 at 17:00 (GMT), 12:00 (US Eastern), 9:00 (US Pacific), 4:00 (Australian EDT - Thursday 14 December)

Register: To participate or receive the recordings register here


Dale Kempf  Ben Gold  Peter Warner

Dale J. Kempf, Ph.D., Distinguished Research Fellow, Director, Neglected Diseases Research, AbbVie

Ben Gold, Ph.D., Associate Professor of Research in Microbiology and Immunology, Weill Cornell Medical College

Peter Warner, Ph.D., Senior Program Officer, Bill and Melinda Gates Foundation

Share this post